Kala Pharmaceuticals Inc
NASDAQ:KALA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kala Pharmaceuticals Inc
NASDAQ:KALA
|
US |
|
Sensus Healthcare Inc
F:5TX
|
US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
Liberty Global PLC
NASDAQ:LBTYA
|
UK |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
|
Kali Metals Ltd
F:6OB
|
AU |
Intrinsic Value
Is KALA undervalued or overvalued?
See the intrinsic value estimate for Kala Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
KALA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with KALA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Kala Pharmaceuticals Does
Kala Pharmaceuticals is a biopharmaceutical company focused on medicines for eye diseases. It develops and sells prescription eye treatments, especially products that are used by eye doctors and patients for conditions such as eye inflammation and dry eye disease. Its business is built around making drugs that can be delivered directly to the eye in a practical, easy-to-use form.
- Headquarters
- United States of America US
- Employees
- 192
- IPO date
- Jul 20, 2017
Revenue & Expenses Breakdown
Kala Pharmaceuticals Inc
Earnings Waterfall
Kala Pharmaceuticals Inc
The intrinsic value for Kala Pharmaceuticals Inc (KALA) under the Base Case is hidden USD.
Compared with the current market price of 0.1758 USD, the stock appears hidden.